MedPage Today reports that thiazolidinediones (aka glitazones) are linked to development of bladder cancer. Pioglitazone is the most commonly used TZD in the U.S. From the article: The increased risk of bladder cancer associated with glitazones — which reached a … Continue reading ![]()
